View Item 

Show simple item record

Primary peritoneal clear cell carcinoma treated with IMRT and interstitial HDR brachytherapy: a case report
dc.contributor.authorJohnson, Skyler B.
dc.contributor.authorPrisciandaro, Joann I.
dc.contributor.authorZhou, Jessica
dc.contributor.authorHadley, Scott W.
dc.contributor.authorReynolds, R. Kevin
dc.contributor.authorJolly, Shruti
dc.date.accessioned2017-01-10T19:09:34Z
dc.date.available2017-01-10T19:09:34Z
dc.date.issued2014-01
dc.identifier.citationJohnson, Skyler B.; Prisciandaro, Joann I.; Zhou, Jessica; Hadley, Scott W.; Reynolds, R. Kevin; Jolly, Shruti (2014). "Primary peritoneal clear cell carcinoma treated with IMRT and interstitial HDR brachytherapy: a case report." Journal of Applied Clinical Medical Physics 15(1): 202-212.
dc.identifier.issn1526-9914
dc.identifier.issn1526-9914
dc.identifier.urihttps://hdl.handle.net/2027.42/135568
dc.publisherICRU
dc.publisherWiley Periodicals, Inc.
dc.subject.otherradiation
dc.subject.otherprimary peritoneal clear cell carcinoma
dc.subject.otherbrachytherapy
dc.subject.otherIMRT
dc.titlePrimary peritoneal clear cell carcinoma treated with IMRT and interstitial HDR brachytherapy: a case report
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/135568/1/acm20202-sup-0018.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/135568/2/acm20202.pdf
dc.identifier.doi10.1120/jacmp.v15i1.4520
dc.identifier.sourceJournal of Applied Clinical Medical Physics
dc.identifier.citedreferenceChi DS, Zivanovic O, Levinson KL, et al. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecol Oncol. 2010; 119 ( 1 ): 38 – 42.
dc.identifier.citedreferenceEvans H, Yates WA, Palmer WE, Cartwright RL, Antemann RW. Clear cell carcinoma of the sigmoid mesocolon: a tumor of the secondary mullerian system. Am J Obstet Gynecol. 1990; 162 ( 1 ): 161 – 63.
dc.identifier.citedreferenceHama Y, Iwasaki Y, Sakata I, Kusano S. Primary peritoneal clear cell carcinoma. J Comput Assist Tomogr. 2004; 28 ( 5 ): 617 – 19.
dc.identifier.citedreferenceIchimura T, Ishiko O, Nishimura S, Kojima T, Shimura K. Primary peritoneal clear cell carcinoma: excellent results from paclitaxel and carboplatin combination chemotherapy. Oncol Rep. 2001; 8 ( 6 ): 1243 – 45.
dc.identifier.citedreferenceLee KR, Verma U, Belinson J. Primary clear cell carcinoma of the peritoneum. Gynecol Oncol. 1991; 41 ( 3 ): 259 – 62.
dc.identifier.citedreferenceMuezzinoglu B, Corak S, Yucesoy I. Primary peritoneal clear cell adenocarcinoma associated with endometriosis. Appl Immunohistochem Mol Morphol. 2011; 19 ( 4 ): 384 – 85.
dc.identifier.citedreferenceTakano M, Yoshikawa T, Kato M, et al. Primary clear cell carcinoma of the peritoneum: report of two cases and a review of the literature. Eur J Gynaecol Oncol. 2009; 30 ( 5 ): 575 – 78.
dc.identifier.citedreferenceTerada T and Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med. 2005; 206 ( 3 ): 271 – 75.
dc.identifier.citedreferenceTziortzioti V, Apessou D, Antoniou S, Giantzoglou A, Paissios P. Clear cell adenocarcinoma of the peritoneum associated with clear cell adenocarcinoma arising in an endometrial polyp. J Obstet Gynaecol. 1999; 19 ( 5 ): 557 – 58.
dc.identifier.citedreferenceBeriwal S, Demanes DJ, Erickson B, et al. American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. Brachytherapy. 2012; 11 ( 1 ): 68 – 75.
dc.identifier.citedreferenceDimopoulos JC, Petrow P, Tanderup K, et al. Recommendations from Gynaecological (GYN) GEC‐ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol. 2012; 103 ( 1 ): 113 – 22.
dc.identifier.citedreferenceHu KS, Enker WE, Harrison LB. High‐dose‐rate intraoperative irradiation: current status and future directions. Semin Radiat Oncol. 2002; 12 ( 1 ): 62 – 80.
dc.identifier.citedreferenceNag S and Hu KS. Intraoperative high‐dose‐rate brachytherapy. Surg Oncol Clin N Am. 2003; 12 ( 4 ): 1079 – 97.
dc.identifier.citedreferenceLangstraat C, Aletti GD, Cliby WA. Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization. Gynecol Oncol. 2011; 123 ( 2 ): 187 – 91.
dc.identifier.citedreferenceKim A, Schreiber D, Rineer J, Choi K, Rotman M. Impact of adjuvant external‐beam radiation therapy in early‐stage uterine papillary serous and clear cell carcinoma. Int J Radiat Oncol Biol Phys. 2011; 81 ( 4 ): e639 – 44.
dc.identifier.citedreferenceThomas M, Mariani A, Wright JD, et al. Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi‐institutional review. Gynecol Oncol. 2008; 108 ( 2 ): 293 – 97.
dc.identifier.citedreferenceTownamchai K, Berkowitz R, Bhagwat M, et al. Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer. Gynecol Oncol. 2013; 129 ( 1 ): 18 – 21.
dc.identifier.citedreferenceBatchelor EC, Watkins JM, Jenrette JM 3rd. Definitive radiotherapy for medically inoperable early‐stage serous and clear cell uterine carcinoma. Radiat Med. 2007; 25 ( 10 ): 536 – 40.
dc.identifier.citedreferenceVarughese J, Hui P, Lu L, Yu H, Schwartz PE. Clear cell cancer of the uterine corpus: the association of clinico‐pathologic parameters and treatment on disease progression. J Oncol. 2011; 2011: 628084.
dc.identifier.citedreferenceBatchelor EC, Watkins JM, Creasman WT, Kohler MF, Sinha D, Jenrette JM. The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma. Eur J Obstet Gynecol Reprod Biol. 2008; 141 ( 2 ): 163 – 68.
dc.identifier.citedreferenceSuzuki M, Saga Y, Tsukagoshi S, Tamura N, Sato I. Recurrent ovarian clear cell carcinoma: complete remission after radiation in combination with hyperthermia; a case study and in vitro study. Cancer Biother Radiopharm. 2000; 15 ( 6 ): 625 – 28.
dc.identifier.citedreferenceTakai N, Utsunomiya H, Kawano Y, Nasu K, Narahara H, Miyakawa I. Complete response to radiation therapy in a patient with chemotherapy‐resistant ovarian clear cell adenocarcinoma. Arch Gynecol Obstet. 2002; 267 ( 2 ): 98 – 100.
dc.identifier.citedreferenceInternational Commission on Radiation Units and Measurements (ICRU). Dose and volume specification for reporting intracavitary therapy in gynecology. ICRU Report No. 38. Bethesda (MD): ICRU; 1985.
dc.identifier.citedreferenceMoll UM, Valea F, Chumas J. Role of p53 alteration in primary peritoneal carcinoma. Int J Gynecol Pathol. 1997; 16 ( 2 ): 156 – 62.
dc.identifier.citedreferenceGoodman MT and Shvetsov YB. Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact? Int J Cancer. 2009; 124 ( 9 ): 2231 – 35.
dc.identifier.citedreferenceWuntakal R and Lawrence A. Are oestrogens and genetic predisposition etiologic factors in the development of clear cell carcinoma of the peritoneum? Med Hypotheses. 2013; 80 ( 2 ): 167 – 71.
dc.identifier.citedreferenceFox H. Primary neoplasia of the female peritoneum. Histopathology. 1993; 23 ( 2 ): 103 – 10.
dc.identifier.citedreferenceJaaback KS, Ludeman L, Clayton NL, Hirschowitz L. Primary peritoneal carcinoma in a UK cancer center: comparison with advanced ovarian carcinoma over a 5‐year period. Int J Gynecol Cancer. 2006; 16 Suppl 1: 123 – 28.
dc.identifier.citedreferenceBarda G, Menczer J, Chetrit A, et al. Comparison between primary peritoneal and epithelial ovarian carcinoma: a population‐based study. Am J Obstet Gynecol. 2004; 190 ( 4 ): 1039 – 45.
dc.identifier.citedreferenceFromm GL, Gershenson DM, Silva EG. Papillary serous carcinoma of the peritoneum. Obstet Gynecol. 1990; 75 ( 1 ): 89 – 95.
dc.identifier.citedreferenceKillackey MA and Davis AR. Papillary serous carcinoma of the peritoneal surface: matched‐case comparison with papillary serous ovarian carcinoma. Gynecol Oncol. 1993; 51 ( 2 ): 171 – 74.
dc.identifier.citedreferenceRoh SY, Hong SH, Ko YH, et al. Clinical characteristics of primary peritoneal carcinoma. Cancer Res Treat. 2007; 39 ( 2 ): 65 – 68.
dc.identifier.citedreferenceNam JH, Kim YM, Jung MH, et al. Primary peritoneal carcinoma: experience with cytoreductive surgery and combination chemotherapy. Int J Gynecol Cancer. 2006; 16 ( 1 ): 23 – 28.
dc.identifier.citedreferenceBloss JD, Brady MF, Liao SY, Rocereto T, Partridge EE, Clarke‐Pearson DL. Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma – a Gynecologic Oncology Group Study. Gynecol Oncol. 2003; 89 ( 1 ): 148 – 54.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
acm20202-sup-0018.pdf
Size:
3.610MB
Format:
PDF
View/Open
Name:
acm20202.pdf
Size:
2.740MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.